Arkolith/Insider Trading/RCKT/Form 4

Rizvi Syed Ali-aamir

Chief Medical OfficerROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed Oct 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 6, 2025Grant(A)63K—$0346K
Oct 6, 2025Grant(A)283K—$0283K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 6, 2025Grant(A)384K—$0384K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-037683) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML